

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.08919345 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.08919345 |
| 3 | protein maturation by protein folding (GO:0022417) | 4.87860708 |
| 4 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.55970186 |
| 5 | pentose-phosphate shunt (GO:0006098) | 4.25324965 |
| 6 | NADH metabolic process (GO:0006734) | 4.16437875 |
| 7 | lysine metabolic process (GO:0006553) | 3.92816786 |
| 8 | lysine catabolic process (GO:0006554) | 3.92816786 |
| 9 | NADPH regeneration (GO:0006740) | 3.89478982 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 3.83069150 |
| 11 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.80199660 |
| 12 | tricarboxylic acid metabolic process (GO:0072350) | 3.75403474 |
| 13 | 2-oxoglutarate metabolic process (GO:0006103) | 3.70505461 |
| 14 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.68025872 |
| 15 | oxaloacetate metabolic process (GO:0006107) | 3.67702402 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.62675744 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 3.61657541 |
| 18 | GDP-mannose metabolic process (GO:0019673) | 3.61126291 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.57858618 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.57858618 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 3.55484905 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55294895 |
| 23 | low-density lipoprotein particle clearance (GO:0034383) | 3.53889900 |
| 24 | protein retention in ER lumen (GO:0006621) | 3.51613942 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 3.37968550 |
| 26 | negative regulation of cell size (GO:0045792) | 3.37189857 |
| 27 | maturation of SSU-rRNA (GO:0030490) | 3.36218186 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 3.28910314 |
| 29 | iron-sulfur cluster assembly (GO:0016226) | 3.22739814 |
| 30 | metallo-sulfur cluster assembly (GO:0031163) | 3.22739814 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.22549321 |
| 32 | growth hormone secretion (GO:0030252) | 3.22079490 |
| 33 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.21539506 |
| 34 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.20556665 |
| 35 | mitotic nuclear envelope reassembly (GO:0007084) | 3.19075719 |
| 36 | nuclear envelope reassembly (GO:0031468) | 3.19075719 |
| 37 | L-phenylalanine catabolic process (GO:0006559) | 3.17468653 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17468653 |
| 39 | succinate metabolic process (GO:0006105) | 3.16837692 |
| 40 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.15563989 |
| 41 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.15563989 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15385569 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.14464366 |
| 44 | vesicle coating (GO:0006901) | 3.08435029 |
| 45 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07385093 |
| 46 | positive regulation of nuclease activity (GO:0032075) | 3.05613766 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.04991802 |
| 48 | regulation of early endosome to late endosome transport (GO:2000641) | 3.04428969 |
| 49 | barbed-end actin filament capping (GO:0051016) | 3.03345367 |
| 50 | sodium ion export (GO:0071436) | 3.03020684 |
| 51 | regulation of cholesterol storage (GO:0010885) | 3.00562368 |
| 52 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.99622011 |
| 53 | negative regulation of microtubule polymerization (GO:0031115) | 2.99394893 |
| 54 | regulation of mitochondrial translation (GO:0070129) | 2.99336447 |
| 55 | pentose metabolic process (GO:0019321) | 2.96511828 |
| 56 | ribosomal small subunit biogenesis (GO:0042274) | 2.95690814 |
| 57 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.94413762 |
| 58 | glucose catabolic process (GO:0006007) | 2.93849573 |
| 59 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.93432627 |
| 60 | protein targeting to mitochondrion (GO:0006626) | 2.93227282 |
| 61 | apoptotic cell clearance (GO:0043277) | 2.92264040 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 2.90972525 |
| 63 | cerebellar Purkinje cell layer development (GO:0021680) | 2.89731357 |
| 64 | nucleotide salvage (GO:0043173) | 2.89649070 |
| 65 | heme biosynthetic process (GO:0006783) | 2.88973361 |
| 66 | aspartate family amino acid catabolic process (GO:0009068) | 2.88499715 |
| 67 | regulation of translational termination (GO:0006449) | 2.87705243 |
| 68 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.85271132 |
| 69 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.85271132 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 2.84906281 |
| 71 | chaperone-mediated protein transport (GO:0072321) | 2.83308641 |
| 72 | valine metabolic process (GO:0006573) | 2.82587613 |
| 73 | cysteine metabolic process (GO:0006534) | 2.81971116 |
| 74 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.81124839 |
| 75 | gluconeogenesis (GO:0006094) | 2.80865401 |
| 76 | pyrimidine-containing compound salvage (GO:0008655) | 2.80563592 |
| 77 | pyrimidine nucleoside salvage (GO:0043097) | 2.80563592 |
| 78 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.78505930 |
| 79 | heme metabolic process (GO:0042168) | 2.78186285 |
| 80 | monosaccharide biosynthetic process (GO:0046364) | 2.76846822 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.76511703 |
| 82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.75058047 |
| 83 | fructose metabolic process (GO:0006000) | 2.74535802 |
| 84 | proteasome assembly (GO:0043248) | 2.73636134 |
| 85 | lipopolysaccharide metabolic process (GO:0008653) | 2.73313673 |
| 86 | hexose biosynthetic process (GO:0019319) | 2.72103564 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72032716 |
| 88 | virion assembly (GO:0019068) | 2.71470227 |
| 89 | macroautophagy (GO:0016236) | 2.70894709 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 2.70614282 |
| 91 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.70367713 |
| 92 | amyloid precursor protein catabolic process (GO:0042987) | 2.70235758 |
| 93 | regulation of nuclease activity (GO:0032069) | 2.69008987 |
| 94 | establishment of protein localization to mitochondrion (GO:0072655) | 2.68921933 |
| 95 | glycosphingolipid catabolic process (GO:0046479) | 2.67747280 |
| 96 | purine nucleotide salvage (GO:0032261) | 2.67335702 |
| 97 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.66537482 |
| 98 | oxidative phosphorylation (GO:0006119) | 2.64806799 |
| 99 | cell communication by electrical coupling (GO:0010644) | 2.64540764 |
| 100 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.64064797 |
| 101 | transferrin transport (GO:0033572) | 2.63125327 |
| 102 | 4-hydroxyproline metabolic process (GO:0019471) | 2.61308792 |
| 103 | positive regulation of fatty acid oxidation (GO:0046321) | 2.60761985 |
| 104 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.60608837 |
| 105 | cellular response to unfolded protein (GO:0034620) | 2.56562073 |
| 106 | proline biosynthetic process (GO:0006561) | 2.56218760 |
| 107 | protein insertion into membrane (GO:0051205) | 2.56156550 |
| 108 | nucleoside salvage (GO:0043174) | 2.55944654 |
| 109 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.55094974 |
| 110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.54917902 |
| 111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54165629 |
| 112 | negative regulation of fibrinolysis (GO:0051918) | 2.53072438 |
| 113 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.52818015 |
| 114 | pinocytosis (GO:0006907) | 2.51663851 |
| 115 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50997732 |
| 116 | ketone body metabolic process (GO:1902224) | 2.50564189 |
| 117 | amino sugar catabolic process (GO:0046348) | 2.50404597 |
| 118 | mitochondrial calcium ion transport (GO:0006851) | 2.50138032 |
| 119 | ER-nucleus signaling pathway (GO:0006984) | 2.49811533 |
| 120 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.48566976 |
| 121 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.48562044 |
| 122 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.48382108 |
| 123 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48066852 |
| 124 | NADP metabolic process (GO:0006739) | 2.48053080 |
| 125 | galactose catabolic process (GO:0019388) | 2.47747664 |
| 126 | establishment of viral latency (GO:0019043) | 2.47197712 |
| 127 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.47069415 |
| 128 | negative regulation of ligase activity (GO:0051352) | 2.47069415 |
| 129 | mannose metabolic process (GO:0006013) | 2.46312919 |
| 130 | plasma lipoprotein particle clearance (GO:0034381) | 2.45957235 |
| 131 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.45873615 |
| 132 | glycolipid catabolic process (GO:0019377) | 2.45418399 |
| 133 | protein localization to mitochondrion (GO:0070585) | 2.45197177 |
| 134 | nitric oxide biosynthetic process (GO:0006809) | 2.44708221 |
| 135 | cellular response to topologically incorrect protein (GO:0035967) | 2.44469456 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.44404241 |
| 137 | ethanol oxidation (GO:0006069) | 2.43684282 |
| 138 | fatty acid homeostasis (GO:0055089) | 2.43664902 |
| 139 | regulation of mitochondrial membrane potential (GO:0051881) | 2.42127748 |
| 140 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.41333170 |
| 141 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.40984739 |
| 142 | negative regulation of lipid transport (GO:0032369) | 2.40958256 |
| 143 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.39199012 |
| 144 | regulation of synapse structural plasticity (GO:0051823) | 2.38846053 |
| 145 | trivalent inorganic cation transport (GO:0072512) | 2.38644582 |
| 146 | ferric iron transport (GO:0015682) | 2.38644582 |
| 147 | fatty acid beta-oxidation (GO:0006635) | 2.38393474 |
| 148 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.38347882 |
| 149 | protein targeting to plasma membrane (GO:0072661) | 2.38164636 |
| 150 | viral protein processing (GO:0019082) | 2.37567840 |
| 151 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.36830912 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.36830912 |
| 153 | regulation of superoxide anion generation (GO:0032928) | 2.36635602 |
| 154 | glyoxylate metabolic process (GO:0046487) | 2.36512410 |
| 155 | activation of protein kinase A activity (GO:0034199) | 2.35211497 |
| 156 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.34997714 |
| 157 | regulation of tight junction assembly (GO:2000810) | 2.34892977 |
| 158 | kynurenine metabolic process (GO:0070189) | 2.34301699 |
| 159 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.34163432 |
| 160 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.34099512 |
| 161 | glutamate metabolic process (GO:0006536) | 2.33715083 |
| 162 | actin nucleation (GO:0045010) | 2.33338484 |
| 163 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.33176665 |
| 164 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.32636526 |
| 165 | cellular response to arsenic-containing substance (GO:0071243) | 2.32340131 |
| 166 | UV protection (GO:0009650) | 2.31630466 |
| 167 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.31511576 |
| 168 | cellular response to nutrient (GO:0031670) | 2.31371348 |
| 169 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.31052123 |
| 170 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.30684492 |
| 171 | de novo posttranslational protein folding (GO:0051084) | 2.30467610 |
| 172 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.30045661 |
| 173 | acetyl-CoA metabolic process (GO:0006084) | 2.29526430 |
| 174 | positive regulation of lamellipodium assembly (GO:0010592) | 2.28889703 |
| 175 | epoxygenase P450 pathway (GO:0019373) | 2.28234617 |
| 176 | protein carboxylation (GO:0018214) | 2.28184607 |
| 177 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.27908557 |
| 178 | ceramide catabolic process (GO:0046514) | 2.27066260 |
| 179 | formation of translation preinitiation complex (GO:0001731) | 2.26626357 |
| 180 | mitochondrial fusion (GO:0008053) | 2.25019658 |
| 181 | deoxyribonucleotide catabolic process (GO:0009264) | 2.24268300 |
| 182 | phagosome maturation (GO:0090382) | 2.24191944 |
| 183 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.23601950 |
| 184 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.22493342 |
| 185 | ATP synthesis coupled proton transport (GO:0015986) | 2.21972664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84175047 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.24262142 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.07399376 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00376589 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95036340 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.93638682 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.91854810 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.85730224 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.79167631 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.74253754 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68213558 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.33152709 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.29117713 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25851167 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25619286 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15000120 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.11354186 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.07457332 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06926947 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05647971 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.99959672 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98991577 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96286622 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.90990771 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90835324 |
| 26 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89499801 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87627149 |
| 28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86912669 |
| 29 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86430588 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84541406 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.83564106 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81467457 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80160959 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78981672 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77445106 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75700139 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74694818 |
| 38 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73787517 |
| 39 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.68663790 |
| 40 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68421136 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.67820339 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64642612 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.62471334 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62297050 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.62124404 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.61884094 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.61002938 |
| 48 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60272763 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.54041110 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53898429 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.53798217 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.52776690 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49980719 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48807291 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47488133 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44882773 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44463063 |
| 58 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43352632 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42850995 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41767241 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41258629 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39655453 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38688168 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37270966 |
| 65 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36875074 |
| 66 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35297741 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.33996396 |
| 68 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33872531 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33689924 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33648908 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33526082 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33481978 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32635458 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30131254 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27904405 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27858523 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27613832 |
| 78 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27396671 |
| 79 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27227184 |
| 80 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.26102312 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25319081 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24605390 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24527627 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23978814 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23237528 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23205461 |
| 87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22918590 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22880773 |
| 89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22448818 |
| 90 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21945041 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21499065 |
| 92 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20896149 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19967689 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18653815 |
| 95 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.17231284 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16875229 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16428994 |
| 98 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14971923 |
| 99 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14547105 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14276326 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13541575 |
| 102 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.11254369 |
| 103 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11193328 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11027362 |
| 105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10789348 |
| 106 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.10555275 |
| 107 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10398203 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09718039 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09367224 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09205848 |
| 111 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09125267 |
| 112 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07415176 |
| 113 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07373636 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06565805 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06331836 |
| 116 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05429705 |
| 117 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05348583 |
| 118 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05276138 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05237002 |
| 120 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05194792 |
| 121 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05160133 |
| 122 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04040548 |
| 123 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04003582 |
| 124 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03861666 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03749155 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02891254 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02072023 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01527358 |
| 129 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01263935 |
| 130 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00690947 |
| 131 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00496905 |
| 132 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00190106 |
| 133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00005336 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99862732 |
| 135 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99225620 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97880013 |
| 137 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.97552090 |
| 138 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.97493459 |
| 139 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97109316 |
| 140 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97087984 |
| 141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96205373 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96164625 |
| 143 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94912623 |
| 144 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94287827 |
| 145 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93772856 |
| 146 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93528390 |
| 147 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92674968 |
| 148 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.92537209 |
| 149 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92435814 |
| 150 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91574793 |
| 151 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.91422804 |
| 152 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90026576 |
| 153 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89378466 |
| 154 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88705095 |
| 155 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88694195 |
| 156 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88132181 |
| 157 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88062072 |
| 158 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87455615 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86832498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.03425906 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.51304785 |
| 3 | MP0008260_abnormal_autophagy | 3.22930952 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.21909374 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.00812570 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.98616575 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.92401787 |
| 8 | MP0005360_urolithiasis | 2.85058097 |
| 9 | MP0005451_abnormal_body_composition | 2.44920938 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.39831603 |
| 11 | MP0005365_abnormal_bile_salt | 2.37184205 |
| 12 | MP0003329_amyloid_beta_deposits | 2.29500177 |
| 13 | MP0003436_decreased_susceptibility_to | 2.24436956 |
| 14 | MP0004130_abnormal_muscle_cell | 2.17570966 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16281120 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.12806994 |
| 17 | MP0000604_amyloidosis | 2.10809198 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.08637969 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.01148172 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.00630334 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.97125635 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.96999857 |
| 23 | MP0009785_altered_susceptibility_to | 1.96388555 |
| 24 | MP0005275_abnormal_skin_tensile | 1.87824549 |
| 25 | MP0001542_abnormal_bone_strength | 1.81798071 |
| 26 | MP0001958_emphysema | 1.80162858 |
| 27 | MP0001661_extended_life_span | 1.79086829 |
| 28 | MP0005025_abnormal_response_to | 1.76257500 |
| 29 | MP0001853_heart_inflammation | 1.70289124 |
| 30 | MP0005332_abnormal_amino_acid | 1.69174364 |
| 31 | MP0002419_abnormal_innate_immunity | 1.68241739 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.66888543 |
| 33 | MP0001756_abnormal_urination | 1.66648602 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.63892812 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.63180578 |
| 36 | MP0005083_abnormal_biliary_tract | 1.62890278 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.62740077 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.55626626 |
| 39 | MP0006082_CNS_inflammation | 1.55498551 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.53904668 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.53000062 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.48137381 |
| 43 | MP0003786_premature_aging | 1.43939019 |
| 44 | MP0000678_abnormal_parathyroid_gland | 1.42092984 |
| 45 | MP0003252_abnormal_bile_duct | 1.41437430 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.41203088 |
| 47 | MP0001727_abnormal_embryo_implantation | 1.40233531 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.38816478 |
| 49 | MP0002723_abnormal_immune_serum | 1.37836402 |
| 50 | MP0000685_abnormal_immune_system | 1.37572209 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.36979010 |
| 52 | MP0005165_increased_susceptibility_to | 1.36644663 |
| 53 | MP0005501_abnormal_skin_physiology | 1.36497961 |
| 54 | MP0005670_abnormal_white_adipose | 1.35938557 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.35754303 |
| 56 | MP0003195_calcinosis | 1.33901177 |
| 57 | MP0006054_spinal_hemorrhage | 1.33487926 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.31962521 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.31960956 |
| 60 | MP0001819_abnormal_immune_cell | 1.31931817 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.30814288 |
| 62 | MP0000609_abnormal_liver_physiology | 1.30526464 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.30313276 |
| 64 | MP0004858_abnormal_nervous_system | 1.30285604 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.30171457 |
| 66 | MP0008469_abnormal_protein_level | 1.29786296 |
| 67 | MP0003279_aneurysm | 1.28329555 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.27884313 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 1.27678949 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27468524 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.26565887 |
| 72 | MP0002090_abnormal_vision | 1.26444396 |
| 73 | MP0003075_altered_response_to | 1.26152250 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.24221746 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.21981624 |
| 76 | MP0003724_increased_susceptibility_to | 1.21325717 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.19924200 |
| 78 | MP0000681_abnormal_thyroid_gland | 1.19626194 |
| 79 | MP0005023_abnormal_wound_healing | 1.19030837 |
| 80 | MP0000750_abnormal_muscle_regeneration | 1.18308952 |
| 81 | MP0001764_abnormal_homeostasis | 1.17383324 |
| 82 | MP0001666_abnormal_nutrient_absorption | 1.17228000 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 1.17186788 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 1.16048718 |
| 85 | MP0002796_impaired_skin_barrier | 1.15204110 |
| 86 | MP0001790_abnormal_immune_system | 1.14727664 |
| 87 | MP0005387_immune_system_phenotype | 1.14727664 |
| 88 | MP0004233_abnormal_muscle_weight | 1.13008977 |
| 89 | MP0000751_myopathy | 1.07445521 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.06861689 |
| 91 | MP0003448_altered_tumor_morphology | 1.06778197 |
| 92 | MP0003763_abnormal_thymus_physiology | 1.06759144 |
| 93 | MP0002405_respiratory_system_inflammati | 1.06757726 |
| 94 | MP0005671_abnormal_response_to | 1.06683915 |
| 95 | MP0000343_altered_response_to | 1.03679823 |
| 96 | MP0002429_abnormal_blood_cell | 1.03117887 |
| 97 | MP0004147_increased_porphyrin_level | 1.02976715 |
| 98 | MP0003186_abnormal_redox_activity | 1.02243298 |
| 99 | MP0000747_muscle_weakness | 1.02214348 |
| 100 | MP0001800_abnormal_humoral_immune | 1.01499890 |
| 101 | MP0000358_abnormal_cell_content/ | 1.01059151 |
| 102 | MP0000716_abnormal_immune_system | 1.00710826 |
| 103 | MP0004947_skin_inflammation | 1.00513485 |
| 104 | MP0002722_abnormal_immune_system | 0.99144853 |
| 105 | MP0002132_abnormal_respiratory_system | 0.99060816 |
| 106 | MP0002060_abnormal_skin_morphology | 0.98664655 |
| 107 | MP0009764_decreased_sensitivity_to | 0.98438043 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.97348543 |
| 109 | MP0003879_abnormal_hair_cell | 0.95535121 |
| 110 | MP0009763_increased_sensitivity_to | 0.95425567 |
| 111 | MP0001243_abnormal_dermal_layer | 0.95056369 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.94042453 |
| 113 | MP0002398_abnormal_bone_marrow | 0.93989770 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.93507929 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.93112822 |
| 116 | MP0001849_ear_inflammation | 0.92962837 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.92784969 |
| 118 | MP0003303_peritoneal_inflammation | 0.92569279 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.91857015 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 0.91857015 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.91118710 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.90703944 |
| 123 | MP0000598_abnormal_liver_morphology | 0.86928820 |
| 124 | MP0001881_abnormal_mammary_gland | 0.86734469 |
| 125 | MP0003693_abnormal_embryo_hatching | 0.86640207 |
| 126 | MP0005187_abnormal_penis_morphology | 0.86390532 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.85527946 |
| 128 | MP0000689_abnormal_spleen_morphology | 0.84823223 |
| 129 | MP0003283_abnormal_digestive_organ | 0.84599537 |
| 130 | MP0009780_abnormal_chondrocyte_physiolo | 0.84358217 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.84213750 |
| 132 | MP0000490_abnormal_crypts_of | 0.84044586 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.81261491 |
| 134 | MP0002269_muscular_atrophy | 0.81053073 |
| 135 | MP0000313_abnormal_cell_death | 0.80615415 |
| 136 | MP0008874_decreased_physiological_sensi | 0.80375258 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.80174939 |
| 138 | MP0005330_cardiomyopathy | 0.79723753 |
| 139 | MP0009278_abnormal_bone_marrow | 0.78036473 |
| 140 | MP0004510_myositis | 0.77702158 |
| 141 | MP0004043_abnormal_pH_regulation | 0.77611667 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.76388556 |
| 143 | MP0004957_abnormal_blastocyst_morpholog | 0.75360048 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.75330107 |
| 145 | MP0008932_abnormal_embryonic_tissue | 0.75044744 |
| 146 | MP0002970_abnormal_white_adipose | 0.73290097 |
| 147 | MP0005636_abnormal_mineral_homeostasis | 0.73252748 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.72165675 |
| 149 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72157406 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.71402207 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.71259876 |
| 152 | MP0001533_abnormal_skeleton_physiology | 0.71121682 |
| 153 | MP0003183_abnormal_peptide_metabolism | 0.70660395 |
| 154 | MP0003091_abnormal_cell_migration | 0.70073310 |
| 155 | MP0003646_muscle_fatigue | 0.69656533 |
| 156 | MP0005464_abnormal_platelet_physiology | 0.69513766 |
| 157 | MP0001348_abnormal_lacrimal_gland | 0.69188222 |
| 158 | MP0004036_abnormal_muscle_relaxation | 0.65773290 |
| 159 | MP0010386_abnormal_urinary_bladder | 0.65747565 |
| 160 | MP0006035_abnormal_mitochondrial_morpho | 0.65324240 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.65093381 |
| 162 | MP0000858_altered_metastatic_potential | 0.65027924 |
| 163 | MP0005503_abnormal_tendon_morphology | 0.64493869 |
| 164 | MP0005166_decreased_susceptibility_to | 0.63930443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.48316312 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 3.43430717 |
| 3 | Ragged-red muscle fibers (HP:0003200) | 3.42773303 |
| 4 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05775888 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05775888 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.98269336 |
| 7 | Xanthomatosis (HP:0000991) | 2.96058449 |
| 8 | Premature rupture of membranes (HP:0001788) | 2.92332158 |
| 9 | Gout (HP:0001997) | 2.87635432 |
| 10 | Hypertensive crisis (HP:0100735) | 2.84058443 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.83831796 |
| 12 | Hand muscle atrophy (HP:0009130) | 2.79298593 |
| 13 | Deep venous thrombosis (HP:0002625) | 2.72205855 |
| 14 | Hypoglycemic coma (HP:0001325) | 2.71901805 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.69145698 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68858807 |
| 17 | Acute necrotizing encephalopathy (HP:0006965) | 2.68486040 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.66848340 |
| 19 | Progressive neurologic deterioration (HP:0002344) | 2.64807723 |
| 20 | Upper limb amyotrophy (HP:0009129) | 2.61852763 |
| 21 | Distal upper limb amyotrophy (HP:0007149) | 2.61852763 |
| 22 | Ketosis (HP:0001946) | 2.61239182 |
| 23 | Ketoacidosis (HP:0001993) | 2.58898208 |
| 24 | Pheochromocytoma (HP:0002666) | 2.56440897 |
| 25 | Hepatosplenomegaly (HP:0001433) | 2.54271934 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.51751005 |
| 27 | Progressive muscle weakness (HP:0003323) | 2.43556060 |
| 28 | Type I transferrin isoform profile (HP:0003642) | 2.41932800 |
| 29 | Rough bone trabeculation (HP:0100670) | 2.41834193 |
| 30 | Polygenic inheritance (HP:0010982) | 2.41373521 |
| 31 | Petechiae (HP:0000967) | 2.40504397 |
| 32 | Microvesicular hepatic steatosis (HP:0001414) | 2.40115969 |
| 33 | Prolonged neonatal jaundice (HP:0006579) | 2.40075077 |
| 34 | Long toe (HP:0010511) | 2.38265424 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.37554878 |
| 36 | Striae distensae (HP:0001065) | 2.36955141 |
| 37 | Mitochondrial inheritance (HP:0001427) | 2.36050573 |
| 38 | Hepatocellular necrosis (HP:0001404) | 2.34225475 |
| 39 | Vertebral compression fractures (HP:0002953) | 2.33933262 |
| 40 | Hyperammonemia (HP:0001987) | 2.31451962 |
| 41 | Acute encephalopathy (HP:0006846) | 2.31448888 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30281982 |
| 43 | Hypokinesia (HP:0002375) | 2.29740485 |
| 44 | Increased intramyocellular lipid droplets (HP:0012240) | 2.29248756 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.26347576 |
| 46 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.25658862 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.23651525 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.22128521 |
| 49 | Dilatation of the ascending aorta (HP:0005111) | 2.22097109 |
| 50 | Global brain atrophy (HP:0002283) | 2.21099527 |
| 51 | Hypercortisolism (HP:0001578) | 2.18295569 |
| 52 | Hepatic necrosis (HP:0002605) | 2.17549593 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.17197089 |
| 54 | Hyperthyroidism (HP:0000836) | 2.16913006 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16815816 |
| 56 | Cervical subluxation (HP:0003308) | 2.15970826 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.15553097 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15553097 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13917196 |
| 60 | Shallow orbits (HP:0000586) | 2.13766137 |
| 61 | Increased CSF lactate (HP:0002490) | 2.11233367 |
| 62 | Back pain (HP:0003418) | 2.11181538 |
| 63 | Oligomenorrhea (HP:0000876) | 2.08773125 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.07690157 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 2.06818059 |
| 66 | Trismus (HP:0000211) | 2.06532843 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.05731632 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.05731632 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 2.05731632 |
| 70 | Abnormal glycosylation (HP:0012345) | 2.05731632 |
| 71 | Onycholysis (HP:0001806) | 2.05211224 |
| 72 | Exercise intolerance (HP:0003546) | 2.04762130 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04286095 |
| 74 | Obstructive lung disease (HP:0006536) | 2.04286095 |
| 75 | Complement deficiency (HP:0004431) | 2.04275836 |
| 76 | Peritonitis (HP:0002586) | 2.04126572 |
| 77 | Generalized amyotrophy (HP:0003700) | 2.03664888 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.02696182 |
| 79 | Broad metatarsal (HP:0001783) | 2.01854322 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01583325 |
| 81 | Loss of speech (HP:0002371) | 2.01148181 |
| 82 | Myokymia (HP:0002411) | 1.99837395 |
| 83 | Mitral stenosis (HP:0001718) | 1.99605067 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 1.99250447 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 1.98452678 |
| 86 | Lactic acidosis (HP:0003128) | 1.98067538 |
| 87 | Progressive macrocephaly (HP:0004481) | 1.96289215 |
| 88 | Aneurysm (HP:0002617) | 1.95989164 |
| 89 | Ankle contracture (HP:0006466) | 1.95954886 |
| 90 | Tetraplegia (HP:0002445) | 1.95902874 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 1.95155944 |
| 92 | Hydroxyprolinuria (HP:0003080) | 1.95155944 |
| 93 | Athetosis (HP:0002305) | 1.94242287 |
| 94 | Achilles tendon contracture (HP:0001771) | 1.93840106 |
| 95 | Skin nodule (HP:0200036) | 1.93708505 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93547077 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93547077 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93547077 |
| 99 | Aortic aneurysm (HP:0004942) | 1.92393491 |
| 100 | Cerebral edema (HP:0002181) | 1.92294981 |
| 101 | Increased serum pyruvate (HP:0003542) | 1.91975152 |
| 102 | Fasciculations (HP:0002380) | 1.91886999 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 1.91419019 |
| 104 | Cholecystitis (HP:0001082) | 1.91419019 |
| 105 | Abnormality of purine metabolism (HP:0004352) | 1.90596553 |
| 106 | Supranuclear gaze palsy (HP:0000605) | 1.90179790 |
| 107 | Neonatal onset (HP:0003623) | 1.89233464 |
| 108 | Testicular atrophy (HP:0000029) | 1.89127830 |
| 109 | Hyperglycinuria (HP:0003108) | 1.89057013 |
| 110 | Abnormality of glycolysis (HP:0004366) | 1.88854942 |
| 111 | Aplastic anemia (HP:0001915) | 1.88609619 |
| 112 | Myoglobinuria (HP:0002913) | 1.88199865 |
| 113 | Entropion (HP:0000621) | 1.87887038 |
| 114 | Increased serum lactate (HP:0002151) | 1.87695206 |
| 115 | Polycythemia (HP:0001901) | 1.87558032 |
| 116 | Purpura (HP:0000979) | 1.86671302 |
| 117 | Nasal polyposis (HP:0100582) | 1.86193500 |
| 118 | Abnormality of the tricuspid valve (HP:0001702) | 1.85189999 |
| 119 | Emotional lability (HP:0000712) | 1.84183639 |
| 120 | Bladder diverticulum (HP:0000015) | 1.83576791 |
| 121 | Aortic dissection (HP:0002647) | 1.82604825 |
| 122 | Conjunctival hamartoma (HP:0100780) | 1.82493264 |
| 123 | Ventricular fibrillation (HP:0001663) | 1.82106541 |
| 124 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.81903757 |
| 125 | Orthostatic hypotension (HP:0001278) | 1.81641060 |
| 126 | Increased serum ferritin (HP:0003281) | 1.81258174 |
| 127 | Cholelithiasis (HP:0001081) | 1.80907076 |
| 128 | Seborrheic dermatitis (HP:0001051) | 1.80472198 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 1.79051644 |
| 130 | Nonimmune hydrops fetalis (HP:0001790) | 1.78916274 |
| 131 | Growth hormone excess (HP:0000845) | 1.78909911 |
| 132 | Personality changes (HP:0000751) | 1.78682366 |
| 133 | Short nail (HP:0001799) | 1.78614873 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 1.78556257 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.78430538 |
| 136 | Spastic paraparesis (HP:0002313) | 1.78096886 |
| 137 | Death in infancy (HP:0001522) | 1.77639973 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.77328977 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.77134524 |
| 140 | Visual hallucinations (HP:0002367) | 1.76634395 |
| 141 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76552616 |
| 142 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76552616 |
| 143 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76552616 |
| 144 | Multiple enchondromatosis (HP:0005701) | 1.76480072 |
| 145 | Respiratory failure (HP:0002878) | 1.76356421 |
| 146 | Torticollis (HP:0000473) | 1.75549517 |
| 147 | Delusions (HP:0000746) | 1.74783865 |
| 148 | Abnormality of the lower motor neuron (HP:0002366) | 1.74639584 |
| 149 | Nail dystrophy (HP:0008404) | 1.74408924 |
| 150 | Eczematoid dermatitis (HP:0000976) | 1.73938848 |
| 151 | Rhabdomyolysis (HP:0003201) | 1.71834035 |
| 152 | Abnormality of the anterior horn cell (HP:0006802) | 1.71653862 |
| 153 | Degeneration of anterior horn cells (HP:0002398) | 1.71653862 |
| 154 | Truncus arteriosus (HP:0001660) | 1.71572996 |
| 155 | Cerebral hypomyelination (HP:0006808) | 1.71464423 |
| 156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71424770 |
| 157 | Vacuolated lymphocytes (HP:0001922) | 1.71241985 |
| 158 | Difficulty climbing stairs (HP:0003551) | 1.70622438 |
| 159 | Late onset (HP:0003584) | 1.70120845 |
| 160 | Neoplasm of head and neck (HP:0012288) | 1.69581586 |
| 161 | Esophageal neoplasm (HP:0100751) | 1.69581586 |
| 162 | Abnormality of complement system (HP:0005339) | 1.69359059 |
| 163 | Enlarged penis (HP:0000040) | 1.69327456 |
| 164 | Abnormality of the intrinsic pathway (HP:0010989) | 1.68427094 |
| 165 | Hypolipoproteinemia (HP:0010981) | 1.68394177 |
| 166 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.67575817 |
| 167 | Abnormality of glycine metabolism (HP:0010895) | 1.67369671 |
| 168 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67369671 |
| 169 | Axonal loss (HP:0003447) | 1.65500529 |
| 170 | Palpitations (HP:0001962) | 1.65119581 |
| 171 | Craniofacial dystonia (HP:0012179) | 1.64490880 |
| 172 | Biconcave vertebral bodies (HP:0004586) | 1.64131449 |
| 173 | Abnormality of the common coagulation pathway (HP:0010990) | 1.64092919 |
| 174 | Spastic diplegia (HP:0001264) | 1.64063163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.22030753 |
| 2 | ERN1 | 3.65357549 |
| 3 | PKN2 | 3.20215596 |
| 4 | IRAK3 | 2.98365747 |
| 5 | NEK1 | 2.62642524 |
| 6 | TESK2 | 2.55016811 |
| 7 | TESK1 | 2.34312234 |
| 8 | BCKDK | 2.20629679 |
| 9 | MAP3K13 | 2.17562649 |
| 10 | STK16 | 2.10400626 |
| 11 | LRRK2 | 2.06832516 |
| 12 | SCYL2 | 1.98532803 |
| 13 | EEF2K | 1.93946631 |
| 14 | SIK1 | 1.89440717 |
| 15 | CAMKK2 | 1.83960604 |
| 16 | RIPK1 | 1.79766971 |
| 17 | MAP3K9 | 1.76906261 |
| 18 | PRKD3 | 1.75623889 |
| 19 | KSR2 | 1.73930168 |
| 20 | CAMKK1 | 1.70650681 |
| 21 | VRK2 | 1.65354677 |
| 22 | TTN | 1.64271220 |
| 23 | ARAF | 1.62671554 |
| 24 | PTK6 | 1.60747745 |
| 25 | TAOK2 | 1.59219261 |
| 26 | LIMK1 | 1.57413413 |
| 27 | LMTK2 | 1.51770467 |
| 28 | EPHA2 | 1.46273944 |
| 29 | PDK2 | 1.44633020 |
| 30 | MAPKAPK3 | 1.41622712 |
| 31 | ABL2 | 1.40448794 |
| 32 | PIM2 | 1.38716950 |
| 33 | MAP3K14 | 1.34550160 |
| 34 | TAOK1 | 1.32170871 |
| 35 | PHKG2 | 1.29746795 |
| 36 | PHKG1 | 1.29746795 |
| 37 | LATS2 | 1.25581582 |
| 38 | TBK1 | 1.22734546 |
| 39 | PAK4 | 1.20787506 |
| 40 | BRAF | 1.20470628 |
| 41 | ILK | 1.19390773 |
| 42 | PDGFRA | 1.18449923 |
| 43 | DAPK3 | 1.17370549 |
| 44 | PAK6 | 1.16230740 |
| 45 | MOS | 1.15663615 |
| 46 | DDR2 | 1.13889308 |
| 47 | MAP2K1 | 1.09434265 |
| 48 | PAK3 | 1.08870761 |
| 49 | TXK | 1.06134842 |
| 50 | FGFR4 | 1.06086982 |
| 51 | RPS6KA4 | 1.05219010 |
| 52 | SRPK1 | 1.03395971 |
| 53 | PBK | 1.03190681 |
| 54 | PTK2 | 0.99137408 |
| 55 | PRKCH | 0.98906669 |
| 56 | RET | 0.96967280 |
| 57 | PRPF4B | 0.95557662 |
| 58 | PDK3 | 0.94410621 |
| 59 | PDK4 | 0.94410621 |
| 60 | DAPK2 | 0.94397063 |
| 61 | NME2 | 0.91767732 |
| 62 | MAP2K7 | 0.91381874 |
| 63 | KDR | 0.90829152 |
| 64 | MAP3K10 | 0.90739222 |
| 65 | AURKA | 0.88855952 |
| 66 | MINK1 | 0.88791124 |
| 67 | MAP3K11 | 0.87635154 |
| 68 | MAP3K2 | 0.86679221 |
| 69 | IKBKE | 0.86574757 |
| 70 | MAP3K8 | 0.84004343 |
| 71 | JAK3 | 0.82849179 |
| 72 | MAP3K12 | 0.80139243 |
| 73 | ALK | 0.79589489 |
| 74 | MARK1 | 0.78932605 |
| 75 | NTRK1 | 0.78586109 |
| 76 | IKBKB | 0.77881412 |
| 77 | FLT3 | 0.77529731 |
| 78 | MAP3K3 | 0.76293581 |
| 79 | MYLK | 0.75054152 |
| 80 | BMX | 0.73767828 |
| 81 | TLK1 | 0.73474725 |
| 82 | BUB1 | 0.73294098 |
| 83 | CSNK1G3 | 0.72743498 |
| 84 | CDK14 | 0.71244036 |
| 85 | IRAK4 | 0.70960116 |
| 86 | CAMK1D | 0.69323424 |
| 87 | CDK19 | 0.69116267 |
| 88 | DAPK1 | 0.67626460 |
| 89 | KIT | 0.66940930 |
| 90 | RPS6KB2 | 0.66572699 |
| 91 | BLK | 0.65261820 |
| 92 | FER | 0.63110981 |
| 93 | PAK2 | 0.62063590 |
| 94 | EIF2AK1 | 0.60363337 |
| 95 | DYRK1B | 0.59745211 |
| 96 | MST1R | 0.59095958 |
| 97 | MAP4K1 | 0.58701304 |
| 98 | CDK15 | 0.57464891 |
| 99 | JAK2 | 0.57184720 |
| 100 | PDPK1 | 0.57184588 |
| 101 | STK38 | 0.56800863 |
| 102 | EPHB1 | 0.54923751 |
| 103 | TAOK3 | 0.54799815 |
| 104 | TYK2 | 0.54315941 |
| 105 | CDK18 | 0.54163129 |
| 106 | GRK7 | 0.53963198 |
| 107 | PRKD1 | 0.53729891 |
| 108 | EPHA3 | 0.52504817 |
| 109 | FES | 0.51384831 |
| 110 | MAP3K5 | 0.51097904 |
| 111 | MAP3K1 | 0.50705405 |
| 112 | CDK11A | 0.50247959 |
| 113 | CSNK1A1L | 0.49942660 |
| 114 | NEK9 | 0.49922336 |
| 115 | MAP4K2 | 0.49831974 |
| 116 | RIPK4 | 0.49333268 |
| 117 | SMG1 | 0.48703918 |
| 118 | KSR1 | 0.48302762 |
| 119 | MAPK11 | 0.47444069 |
| 120 | WNK3 | 0.46814757 |
| 121 | GRK6 | 0.44765760 |
| 122 | MAP2K4 | 0.44694757 |
| 123 | STK10 | 0.44425480 |
| 124 | CDK4 | 0.43464313 |
| 125 | FGFR1 | 0.43454534 |
| 126 | PRKCZ | 0.42970726 |
| 127 | EPHB2 | 0.42670451 |
| 128 | MTOR | 0.41972319 |
| 129 | PDK1 | 0.40245338 |
| 130 | CAMK2G | 0.39856918 |
| 131 | CSK | 0.39374571 |
| 132 | PAK1 | 0.39296965 |
| 133 | BMPR2 | 0.39244383 |
| 134 | JAK1 | 0.39132792 |
| 135 | DYRK3 | 0.38901429 |
| 136 | IRAK2 | 0.38584650 |
| 137 | MAP2K3 | 0.38459447 |
| 138 | CSF1R | 0.38430467 |
| 139 | ZAP70 | 0.37967194 |
| 140 | ACVR1B | 0.37593084 |
| 141 | RAF1 | 0.36652884 |
| 142 | FGR | 0.35046531 |
| 143 | PRKCG | 0.33996620 |
| 144 | RPS6KA5 | 0.33874076 |
| 145 | TGFBR2 | 0.33833914 |
| 146 | AKT2 | 0.33578621 |
| 147 | PRKAA1 | 0.32967965 |
| 148 | SRC | 0.32645998 |
| 149 | PRKG2 | 0.29944872 |
| 150 | CSNK1G1 | 0.29288386 |
| 151 | MATK | 0.27057900 |
| 152 | MAPKAPK2 | 0.27040232 |
| 153 | CLK1 | 0.25406785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.03075477 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51415557 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.46199420 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.22768606 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.59232986 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.39458147 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30693672 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28517639 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23833191 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15949527 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07661494 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.04342848 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.97838485 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.96963404 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96281920 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94815489 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.93048075 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83562455 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82186974 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76796437 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76627499 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.76252262 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74266361 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.74059272 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.70779099 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67553285 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62283788 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.59818153 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57099337 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54810714 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.52113267 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52003948 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49206316 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43752828 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43558790 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42491628 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41816116 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.39237610 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36657687 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31219554 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30410153 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.24512381 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21758488 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.16937050 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15130783 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13422533 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.13042210 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12256310 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.12043150 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11333797 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10879140 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08809854 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08591759 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06776242 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06761689 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04513230 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03864099 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03516592 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 1.02754854 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01915824 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00239572 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99550859 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97296380 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.95742063 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91711548 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91570518 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90548976 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87830506 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86915357 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86563800 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85484958 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.83312599 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.82295954 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80211713 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78003332 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77676372 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.77609769 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77010764 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76774292 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74732594 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.72810614 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71603249 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.71422292 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69438009 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68750722 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66473930 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65682736 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.63553366 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63160211 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61097518 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60254220 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60169751 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.60075517 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.59737123 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59651310 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59440205 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.57786576 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57528447 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56899323 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56861000 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56585882 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56386382 |
| 103 | Mismatch repair_Homo sapiens_hsa03430 | 0.53980985 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.52649679 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52639482 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52290362 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51872963 |
| 108 | Proteasome_Homo sapiens_hsa03050 | 0.51066844 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51017932 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50270437 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49766596 |
| 112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49241088 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.48770856 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47777329 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47727943 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47132731 |
| 117 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46995671 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.46948173 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46663870 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46530293 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45942295 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45901114 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.44370585 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44113582 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43718339 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43053527 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.41417469 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.41115908 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39652684 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39035211 |
| 131 | Protein export_Homo sapiens_hsa03060 | 0.37605535 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36907130 |
| 133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36821908 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36782406 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36763033 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36274193 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36141686 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36119606 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35408029 |
| 140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34859984 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.34586759 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34246699 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33247260 |
| 144 | Insulin secretion_Homo sapiens_hsa04911 | 0.32586659 |
| 145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32300646 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31613777 |
| 147 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31046152 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29701603 |
| 149 | Salmonella infection_Homo sapiens_hsa05132 | 0.27309136 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26923128 |
| 151 | Focal adhesion_Homo sapiens_hsa04510 | 0.26574308 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26415374 |
| 153 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25211595 |
| 154 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25106318 |

